Search results
Author(s):
Faiez Zannad
Added:
1 year ago
ESC Congress 22 — Dr Faiez Zannad (University of Lorraine, FR) joins us onsite at ESC to provide an update on the EMPEROR-Pooled trial, a pooled analysis of the EMPEROR-Preserved and EMPEROR-Reduced studies which aimed to evaluate the effects of empagliflozin on patients with heart failure.
9718 patients with heart failure were pooled into the study, where it was found that the use of…
View more
GDMT for Heart Failure
Author(s):
Edgar Francisco Carrizales-Sepúlveda
,
Alejandro Ordaz-Farías
,
José Arturo Vargas-Mendoza
,
et al
Added:
3 weeks ago
Article
Author(s):
Giuseppe Rosano
,
Cristiana Vitale
Added:
3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1–3 It is a complex syndrome, characterised by a spectrum of symptoms and signs ranging from minimal loss of normal functional capacity to more severe symptoms refractory to medical therapy. It may be associated with different aetiologies and varying degrees of…
View more
Justin Ezekowitz
Author
Author(s):
Shelley Zieroth
,
Javed Butler
,
Carolyn Lam
Added:
1 year ago
In this symposium, part of Heart Failure Online 2022, we focus on the management of HFpEF and hear from an esteemed faculty on the totality of evidence that places SGLT-2 inhibitors as the only drug class to significantly improve mortality and morbidity in patients with a left ventricular ejection fraction >40%.
In addition to hearing about the data which led to changes in the recent…
View more
Shelley Zieroth
Research Area(s) / Expertise:
Job title: Director, Heart Failure and Heart Transplant Clinics
Author
Author(s):
Mikhail Kosiborod
,
Shelley Zieroth
,
Andrew JS Coats
,
et al
Added:
1 year ago
This series of peer-to-peer discussions examines the practicalities of personalising heart failure management in the context of recent changes to international clinical practice guidelines.
At this exciting juncture, we now have two SGLT-2 inhibitors that offer clinical benefit across the spectrum of ejection fraction, and an increasing body of real-world and registry-based data showing…
View more
SGLT2 Inhibition in Heart Failure: New Updates
Video Series
e-SPACE Heart Failure 2021
Video Series
Treatment of the Diabetic Heart Failure Patient
Author(s):
Mikhail Kosiborod
,
Mark Petrie
Added:
3 years ago
Video Series